Inventor · disambiguated record
Ewa Budzynski
Also filed as: BUDZYNSKI EWA
0 granted patents·6 pending applications·0 citations·filing 2021–2023
Files withREGENXBIO INC6
Top patents by PatentIndex Score
6 records- 0160US2025288697A1Vectorized anti-tnf-alpha inhibitors for ocular indicationsREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0252US2025339555A1Formulations for suprachoroidal administration such as formulations with aggregate formationREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0350US2023391864A1Vectorized anti-tnf-alpha antibodies for ocular indicationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0445US2024024508A1Formulations for suprachoroidal administration such as high viscosity formulationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0545US2023414788A1Formulations for suprachoroidal administration such as gel formulationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0642US2023372538A1Formulations for suprachoroidal administration such as formulations with aggregate formationREGENXBIO INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ewa Budzynski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →